Moderate and Severe Chronic Kidney Disease Therapeutics Report 2024: Comprehensive Insights about 50+ Companies and 50+ Pipeline Drugs Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "Moderate and Severe Chronic Kidney Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...

State of the Art Advancements in Chronic Kidney Disease Treatments - A Deep Dive into the 2024 Pipeline Insight Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Chronic Kidney Disease - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.A recent comprehensive analysis reveals...

Global Chronic Kidney Disease Drugs Market to Surpass US$ 17,832.5 Million by 2030, Says Coherent Market Insights (CMI) Seattle, Oct. 19, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global chronic kidney disease drugs market is estimated to be valued at US$ 13,220.0 million in 2022 and is...